ZWZhao-Ying Wang

Zhao-Ying Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhao-Ying Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Liu

    Key Laboratory of Children Urogenital Development and Tissue Engineering, Key Laboratory of Children's Development and Disorders of the Ministry of Education, National Clinical Research Center for Children's Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing 400014, China

    1 shared publication
  • Da-Wei He

    Key Laboratory of Children Urogenital Development and Tissue Engineering, Key Laboratory of Children's Development and Disorders of the Ministry of Education, National Clinical Research Center for Children's Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing 400014, China

    1 shared publication
  • Dawei He

    Department of Urology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, the Laboratory of Targeted Delivery of Traditional Chinese Medicine, China

    1 shared publication
  • Guanghui Wei

    Department of Urology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, 400014, Chongqing, China; Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, Children Urogenital Development and Tissue Engineering of Chongqing Education Commission of China, 400014, Chongqing, China

    1 shared publication
  • Hongxu Lu

    Department of Urology Children’s Hospital of Chongqing Medical University Chongqing 400014 China cqmu.edu.cn

    1 shared publication
  • Jinkui Wang

    Department of Pediatrics

    1 shared publication

Latest Publications

  • Open Access

    Human Mesenchymal Stem Cells-Derived Exosome Mimetic Vesicles Regulation of the MAPK Pathway and ROS Levels Inhibits Glucocorticoid-Induced Apoptosis in Osteoblasts

    by Hongxu Lu, Zhaoxia Zhang, Zhaoying Wang, Jinkui Wang, Tao Mi, Liming Jin, Xin Wu, Junyi Luo, Yimeng Liu, Junhong Liu, et al.

    Background. Long-term extensive use of glucocorticoids will lead to hormonal necrosis of the femoral head, and osteoblasts play an important role in the prevention of osteonecrosis. However, there is no complete cure for necrosis of the femoral head. Mesenchymal stem cell- (MSCs-) derived exosomes are widely used for the repair of various tissue lesions. Therefore, the aim of this study was to investigate the mechanism of dexamethasone- (DEX-) induced osteoblast apoptosis and the therapeutic effect of human umbilical cord MSC- (hucMSC-) derived exosome mimetic vesicles (EMVs) on osteoblast-induced apoptosis by DEX. Methods. The viability and apoptosis of primary MC3T3-E1 cells were determined by the Cell Counting Kit-8 (CCK-8), FITC-Annexin V/PI staining and immunoblot. The intracellular levels of reactive oxygen species (ROS) after DEX treatment were measured by 2, 7 -dichlorodihydrofluorescein diacetate (DCFH-DA) staining. In this study, hucMSC-EMVs and N-acetyl-l-cysteine (NAC) were used as therapeutic measures. The expression of B-cell lymphoma 2-associated X, Bcl 2, HO-1, and nuclear factor erythroid-derived 2-like 2 and MAPK- signaling pathway in osteogenic cell MC3T3-E1 cells treated with Dex was analyzed by the immunoblotting. Results. DEX significantly induced osteoblasts MC3T3-E1 apoptosis and ROS accumulation. MAPK-signaling pathway was activated in MC3T3-E1 after DEX treatment. hucMSC-EMVs intervention significantly downregulated DEX-induced MAPK-signaling pathway activation and ROS accumulation. In addition, hucMSC-EMVs can reduce the apoptosis levels in osteoblast MC3T3-E1 cells induced by DEX. Conclusions. Our study confirmed that hucMSC-EMVs regulates MAPK-signaling pathway and ROS levels to inhibit DEX-induced osteoblast apoptosis.


  • 经膀胱颈部分结扎建立膀胱输尿管返流性肾损害动物模型

    by Zhao-Ying Wang, Zhao-Xia Zhang, Li-Ming Jin, Bo Liu, Lian-Ju Shen, Da-Wei He, Guang-Hui Wei

    建立一种膀胱出口梗阻导致的返流性肾损害动物模型。 取6~8周龄雄性C57BL/6小鼠60只,随机划分为对照组、假手术组和膀胱颈部分结扎(PBOO)组,每组20只,PBOO组小鼠麻醉后开腹分离膀胱颈,用0.3 mm直径的金属棒引导部分结扎膀胱颈,假手术组仅开腹分离膀胱颈,不结扎,对照组不做处理。术后7 d,每组随机挑选12只存活的小鼠,观察膀胱、输尿管、肾盂和肾脏大体变化,行经膀胱逆行性尿路造影,取肾组织进行组织病理学分析,Western blot、免疫荧光和免疫组化分别检测波形蛋白、增殖细胞核抗原(PCNA)、α平滑肌肌动蛋白 (α-SMA)表达水平。 与对照组和假手术组相比,PBOO组小鼠膀胱、输尿管、肾盂明显扩张,膀胱输尿管返流明显,肾脏体积和质量增加(PPP<0.000 1)。 小鼠行PBOO术后,膀胱、输尿管、肾脏均发生明显形态改变,并出现返流性肾纤维化样损害,可以作为研究膀胱出口梗阻导致的肾纤维化病理改变机制及治疗措施的动物模型。